Bruker Corp (BRKR)
70.61
-8.33
(-10.55%)
USD |
NASDAQ |
May 02, 10:59
Bruker Cash from Operations (TTM): 350.10M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 350.10M |
September 30, 2023 | 316.10M |
June 30, 2023 | 341.50M |
March 31, 2023 | 284.10M |
December 31, 2022 | 274.40M |
September 30, 2022 | 241.50M |
June 30, 2022 | 195.90M |
March 31, 2022 | 262.20M |
December 31, 2021 | 282.40M |
September 30, 2021 | 346.80M |
June 30, 2021 | 405.30M |
March 31, 2021 | 395.20M |
December 31, 2020 | 332.20M |
September 30, 2020 | 265.40M |
June 30, 2020 | 235.40M |
March 31, 2020 | 234.20M |
December 31, 2019 | 213.40M |
September 30, 2019 | 209.50M |
June 30, 2019 | 184.60M |
March 31, 2019 | 210.10M |
December 31, 2018 | 239.70M |
September 30, 2018 | 211.10M |
June 30, 2018 | 218.90M |
March 31, 2018 | 165.60M |
December 31, 2017 | 154.40M |
Date | Value |
---|---|
September 30, 2017 | 141.50M |
June 30, 2017 | 142.10M |
March 31, 2017 | 177.40M |
December 31, 2016 | 130.80M |
September 30, 2016 | 189.60M |
June 30, 2016 | 207.80M |
March 31, 2016 | 188.20M |
December 31, 2015 | 229.20M |
September 30, 2015 | 148.90M |
June 30, 2015 | 108.30M |
March 31, 2015 | 122.80M |
December 31, 2014 | 114.30M |
September 30, 2014 | 176.40M |
June 30, 2014 | 201.40M |
March 31, 2014 | 181.70M |
December 31, 2013 | 145.00M |
September 30, 2013 | 104.50M |
June 30, 2013 | 66.30M |
March 31, 2013 | 110.10M |
December 31, 2012 | 133.10M |
September 30, 2012 | 134.30M |
June 30, 2012 | 155.20M |
March 31, 2012 | 121.90M |
December 31, 2011 | 87.70M |
September 30, 2011 | 89.00M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
184.60M
Minimum
Jun 2019
405.30M
Maximum
Jun 2021
282.64M
Average
274.40M
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
Azenta Inc | 70.94M |
Harvard Bioscience Inc | 14.03M |
Bionano Genomics Inc | -125.18M |
Akoya Biosciences Inc | -50.90M |
Singular Genomics Systems Inc | -73.65M |